Biomarkers in Immuno-oncology

Immuno-oncology’s challenge is to orchestrate a biomarker program in an exceedingly extremely competitive drug development landscape knowing that before having vital clinical expertise, the program is unlikely to yield the kinds of binary measurements wont to outline and choose a patient population for a targeted medical care.

 

  • Tumor-infiltrating immune cells
  • Immune cell populations / phenotypes
  • Cytokine profiles
  • Tumor mutation burden / genomic mutation profiling
  • Gene expression signatures

Related Conference of Biomarkers in Immuno-oncology

Biomarkers in Immuno-oncology Conference Speakers